$Psyence Biomedical (PBM.US)$ Psyence Biomedical Shares Are ...

$Psyence Biomedical (PBM.US)$ Psyence Biomedical Shares Are Trading Higher After the Company Announced the Recruitment of Its Australia-based Empax Center as the Second Trial Site for Psyence's Biomed Ongoing Phase IIb Clinical Trial of Nature-derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care